- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01419418
Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes
A Study of Patients' Perspectives of Factors That Support the Management of Cardiac Care for Improved Outcomes in a Peripheral Arterial Disease Population
Specific Aims: To delve into the complex phenomena of living with Peripheral Arterial Disease (PAD), and to investigate the patients' perspective of the factors that affects their decisions regarding management of their PAD.
a) Utilize a qualitative approach to uncover factors that patients perceive support the management of their condition utilizing a purposive sampling of Peripheral Arterial Disease patients.
- To determine what they believe to be effective tools to support themselves to improve their condition.
- To determine from the patient's perspective if adherence to prescribed medical regimes are important for them to improve their PAD outcomes.
- To describe the patient factors of those who are self reported adherent compared to those who are not or unable to their prescribed regimen.
Study Overview
Status
Conditions
Detailed Description
Cardiovascular Diseases (CVD) affects as many lives each year as cancer, chronic lower respiratory diseases, accidents and diabetes mellitus combined. One in three American adults (about 80,000,000) has one or more types of cardiovascular disease. Prevention and management of CVD is a public health goal, yet, it remains a major challenge. Even hypertension, which is easily detected and usually controllable, has only a 50 percent control rate.
Peripheral Arterial Disease (PAD) is one type of CVD, which affects about eight million Americans and is also associated with significant morbidity and mortality. PAD increases with age and disproportionately affects African Americans. Interestingly, despite its prevalence and cardiovascular risk implications, only 20 to 30 percent of PAD patients are undergoing treatment.
Medical management of these diseases has substantially contributed to improved morbidity and mortality. However, for the medical therapies to be successful the patients need to take their medications and adjust their lifestyles, as prescribed. Overall, "typical adherence rates for the general population are about 50 percent for medications and are much lower for lifestyle prescriptions and other more behaviorally demanding regimens". Few studies have investigated the reactions and thoughts regarding the efficacy of therapies/interventions from the perspective of the participants. Meta analyses on adherence have also revealed that the patients' perspectives are often absent and that present adherence theories are more successful in explaining non-adherence than improving adherence. Therefore, it is important to understand, from the perspective of the patient; the factors they believe improve their cardiac outcomes with an emphasis on the adherence to prescribed therapies.
This qualitative study will investigate the question: What are patients' perspectives of factors that support the management of their cardiovascular condition to improve outcomes in a Peripheral Arterial Disease population? Cardiac outcomes of interest are health status defined by symptom burden, functional status, and health related quality of life, patients' perception of the quality of care that they receive, and the experience of living with PAD.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80220
- VA ECHCS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Diagnosis of Peripheral Arterial Disease
Exclusion Criteria:
Unable to converse about the topic under investigation for up to one hour for multiple visits
Pregnancy
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Peripheral Arterial Disease (PAD)
This is a longitudinal observational study.
There were no interventions administered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' perspective of the factors that affects their decisions regarding management of their PAD
Time Frame: 1 year
|
Qualitative interview that will collect patients perspectives and will be analyzed for thoughts, opinions, feelings, and concepts.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative Morinsky's Medication adherence survey
Time Frame: 1 year
|
Morinsky's Medication adherence survey will be administered at baseline and one year to assess self report medication adherence.
|
1 year
|
|
Quantitative PAQ health status survey
Time Frame: 1 year
|
PAQ health status will be administered at the initial visit as well as the last one-on-one interview to assess disease specific health status.
|
1 year
|
|
Quantitative EQ-5D health status survey
Time Frame: 1 year
|
survey will be administered at the initial visit as well as the last one-on-one interview to assess overall health status.
|
1 year
|
|
Quantitative Stage of Change Survey
Time Frame: 1 year
|
Stage of Change motivational survey will be administered at the initial visit as well as the last one-on-one interview to assess patients motivational status.
|
1 year
|
|
Quantitative SEAMS survey
Time Frame: 1 year
|
SEAMS self efficacy survey will be administered at the initial visit as well as the last one-on-one interview to assess patient self efficacy to adhere to medication treatment.
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anne C Lambert-Kerzner, PhD, MSPH, VAMC in Denver, Co.
- Study Director: Thomas Tsai, MD, VAMC Denver, Co.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-1361
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Diseases
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Wroclaw Medical UniversityPoznan University of Medical Sciences; Military Institute of Medicine National...RecruitingPeripheral Arterial Disease(PAD)Poland
-
OrbusNeichEucatech AG; Centre Européen de Recherche CardiovasculaireRecruitingPeripheral Arterial Disease | Peripheral Arterial Occlusive DiseaseSpain, Singapore, Belgium, Germany
-
Louisiana State University Health Sciences Center...Not yet recruitingPeripheral Arterial Disease(PAD)United States
-
BayerCompleted
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Marissa JarosinskiTerminatedPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
TakedaCompletedPeripheral Arterial DiseasesGeorgia, Kazakhstan, Russian Federation
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany